Trial intelligence / Profile preview

Vigabatrin for Cocaine Self-Administration

NCT00373581Phase 2Terminated

Sponsor
New York State Psychiatric Institute
Start
Apr 2006
Primary completion
Dec 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in cocaine dependence comparing Vigabatrin Sequence with Placebo Sequence (2 arms). Primary endpoints: Subjective effects, Cardiovascular effects and 2 more. Started Apr 2006; status: terminated.

02

Drugs

vigabatrin
03

Conditions

cocaine dependence

Beyond the preview

Go deeper on NCT00373581.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00373581.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call